181 related articles for article (PubMed ID: 9046645)
21. Hypopigmented mycosis fungoides in childhood and adolescence.
Neuhaus IM; Ramos-Caro FA; Hassanein AM
Pediatr Dermatol; 2000; 17(5):403-6. PubMed ID: 11085673
[TBL] [Abstract][Full Text] [Related]
22. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of the results obtained with ultraviolet radiation and photochemotherapy in the early stages of mycosis fungoides].
Piccinno R; Caccialanza M; Mainardi L
G Ital Dermatol Venereol; 1990 Mar; 125(3):91-5. PubMed ID: 2376422
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
[TBL] [Abstract][Full Text] [Related]
27. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Hammar H; Molin L; Volden G
Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
29. [Combined therapy of psoralen plus ultraviolet A followed by narrow band ultraviolet B photochemotherapy for early stage mycosis fungoides].
Wang T; Liu Y; Zheng H; Zuo Y; Fang K
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):626-8. PubMed ID: 25430032
[TBL] [Abstract][Full Text] [Related]
30. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
31. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
32. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
Monk BE; Vollum DI; du Vivier AW
Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
[No Abstract] [Full Text] [Related]
33. Conjunctival involvement with mycosis fungoides in a patient receiving PUVA therapy.
O'Day J; Rotstein H; Weiner JM
Ophthalmology; 1985 Jan; 92(1):109-13. PubMed ID: 3974989
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
Shintani Y; Nishida E; Furuhashi T; Muramatsu S; Kubo R; Nakamura M; Watanabe S; Masuda H; Ikumi K; Matsumoto K; Yamazaki S; Morita A
J Dermatol; 2022 Feb; 49(2):239-245. PubMed ID: 34309912
[TBL] [Abstract][Full Text] [Related]
35. Photochemotherapy for mycosis fungoides: long-term followup study.
Roenigk HH
Cancer Treat Rep; 1979 Apr; 63(4):669-73. PubMed ID: 445519
[TBL] [Abstract][Full Text] [Related]
36. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment.
Swanbeck G; Roupe G; Sandström MH
Acta Derm Venereol; 1994 Nov; 74(6):465-6. PubMed ID: 7701883
[TBL] [Abstract][Full Text] [Related]
37. Treatment of mycosis fungoides with psoralen and long-wave ultraviolet light-A (PUVA).
Nozicková M; Simková M; Nozicka Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):179-94. PubMed ID: 3481871
[No Abstract] [Full Text] [Related]
38. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
39. Dermoscopic findings of psoralen and ultraviolet A therapy lentigines resembling melanoma in a patient with mycosis fungoides.
Sakurai M; Nakamura M; Ikumi K; Kato H; Morita A
J Dermatol; 2021 Nov; 48(11):e526-e527. PubMed ID: 34350620
[No Abstract] [Full Text] [Related]
40. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]